Cadila

Cadila Healthcare Limited is an Indian multinational pharmaceutical company, headquartered in Ahmedabad, Gujarat. Founded in 1952 by Shantilal H. Thakore, the company has grown to become one of the largest pharmaceutical companies in India. Cadila is known for its wide range of products, including generic drugs, branded pharmaceuticals, and over-the-counter medicines. The company operates through a network of manufacturing facilities, research and development centers, and marketing offices across India and internationally.

Cadila's product portfolio spans various therapeutic areas, such as cardiovascular, central nervous system, dermatology, gastroenterology, and respiratory diseases. The company is also involved in the development of biosimilars, which are similar biological products to existing licensed biological medicines. This includes the development of biosimilars for insulin and other therapeutic proteins.

Cadila Healthcare has a strong focus on research and development, investing significantly in innovation and technology to meet the evolving needs of the healthcare industry. The company has collaborations with several international pharmaceutical companies and academic institutions to enhance its research capabilities.

In terms of corporate social responsibility, Cadila Healthcare is committed to contributing to the betterment of society. The company engages in various initiatives, including healthcare awareness programs, community health initiatives, and environmental sustainability efforts.

Cadila Healthcare is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company's shares are traded under the symbol CADILAHC. As of recent years, Cadila Healthcare has been recognized for its consistent performance and growth in the pharmaceutical industry.